Literature DB >> 2164050

The role of fibronectin binding in the rat model of experimental endocarditis caused by Streptococcus sanguis.

J H Lowrance1, L M Baddour, W A Simpson.   

Abstract

Inactivation of fibronectin (Fn) binding by insertional mutagenesis of Streptococcus sanguis with Tn916 reduces virulence of this bacterium in the rat model of infective endocarditis (IE). Transconjugants were screened for Fn adherence using an ELISA adherence test. One transconjugant had a decreased adherence to immobilized Fn. Southern hybridization demonstrated that the insertion occurred only once in this mutant. The parent strain and mutant strain JL113 were used as challenge strains in a rat endocarditis model. These experiments demonstrated that the mutant had a reduced ability (P less than 0.05) to produce IE. Spontaneous excision of Tn916 from JL113 produced strains identical to both the parental and mutant phenotypes. One strain (JLR-19) that retained the mutant phenotype and one (JLR-15) that regained the parental phenotype for Fn binding were tested for their ability to produce IE. These strains demonstrated that the ability to bind Fn and to produce IE were correlated after Tn916 excision. The reduced virulence of the mutant suggested that adherence of S. sanguis to immobilized Fn plays an important role in the production of IE.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164050      PMCID: PMC296682          DOI: 10.1172/JCI114717

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Binding of soluble form of fibroblast surface protein, fibronectin, to collagen.

Authors:  E Engvall; E Ruoslahti
Journal:  Int J Cancer       Date:  1977-07-15       Impact factor: 7.396

3.  Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate.

Authors:  G M Wahl; M Stern; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  Experimental bacterial endocarditis. I. Colonization of a sterile vegetation.

Authors:  D T Durack; P B Beeson
Journal:  Br J Exp Pathol       Date:  1972-02

5.  Binding and factor XIIIa-mediated cross-linking of a 27-kilodalton fragment of fibronectin to Staphylococcus aureus.

Authors:  D F Mosher; R A Proctor
Journal:  Science       Date:  1980-08-22       Impact factor: 47.728

6.  Twitching motility and possession of polar fimbriae in spreading Streptococcus sanguis isolates from the human throat.

Authors:  S D Henriksen; J Henrichsen
Journal:  Acta Pathol Microbiol Scand B       Date:  1975-04

Review 7.  Pathogenesis of experimental endocarditis.

Authors:  L M Baddour; G D Christensen; J H Lowrance; W A Simpson
Journal:  Rev Infect Dis       Date:  1989 May-Jun

8.  Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin.

Authors:  W M Scheld; J A Valone; M A Sande
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

9.  Rat model of experimental endocarditis.

Authors:  J Santoro; M E Levison
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

10.  Physiological differentiation of viridans streptococci.

Authors:  R R Facklam
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948

View more
  33 in total

1.  Invasion and killing of human endothelial cells by viridans group streptococci.

Authors:  Murray W Stinson; Susan Alder; Sarmishtha Kumar
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

2.  The cellular form of human fibronectin as an adhesion target for the S fimbriae of meningitis-associated Escherichia coli.

Authors:  A Sarén; R Virkola; J Hacker; T K Korhonen
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Bartonella henselae Pap31, an extracellular matrix adhesin, binds the fibronectin repeat III13 module.

Authors:  S M Dabo; A W Confer; B E Anderson; Snehalata Gupta
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  Curcumin suppresses Streptococcus mutans adherence to human tooth surfaces and extracellular matrix proteins.

Authors:  J Song; B Choi; E-J Jin; Y Yoon; K-H Choi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-19       Impact factor: 3.267

Review 5.  Multiple adhesins of streptococci.

Authors:  D L Hasty; I Ofek; H S Courtney; R J Doyle
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

6.  Contribution of sialic acid-binding adhesin to pathogenesis of experimental endocarditis caused by Streptococcus gordonii DL1.

Authors:  Yukihiro Takahashi; Eizo Takashima; Kisaki Shimazu; Hisao Yagishita; Takaaki Aoba; Kiyoshi Konishi
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

7.  Glucosyltransferase mediates adhesion of Streptococcus gordonii to human endothelial cells in vitro.

Authors:  A M Vacca-Smith; C A Jones; M J Levine; M W Stinson
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  FimA, a major virulence factor associated with Streptococcus parasanguis endocarditis.

Authors:  D Burnette-Curley; V Wells; H Viscount; C L Munro; J C Fenno; P Fives-Taylor; F L Macrina
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  Platelet receptors for the Streptococcus sanguis adhesin and aggregation-associated antigens are distinguished by anti-idiotypical monoclonal antibodies.

Authors:  K Gong; D Y Wen; T Ouyang; A T Rao; M C Herzberg
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis.

Authors:  P Moreillon; J M Entenza; P Francioli; D McDevitt; T J Foster; P François; P Vaudaux
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.